Taken together, our results suggest that targeting METTL3 to reduce ABCC2 expression in cytomembrane may be one of major causes for improving the chemosensitivity of NSCLC cells to PTX or CBP. The gene discussed is METTL3; the disease is non-small cell lung carcinoma.